Localized and metastatic cancers give rise to circulating tumor cells (CTCs) which are
detectable in the bloodstream. Recent studies have highlighted the prognostic significance …

Circulating tumor cells (CTCs) are rare malignant cells found in the peripheral blood that
originate from the primary tumor or metastatic sites. New techniques have been developed …

Abstract Background Circulating tumor cells (CTCs) have long been considered a reflection
of tumor aggressiveness. Hematogenous spreading of CTCs from a primary tumor is a …

Circulating tumor cells (CTCs) represent a surrogate biomarker of hematogenous
metastases. In recent years, their detection has gained increasing interest. There is ample …

The presence of circulating tumor cells (CTCs) in peripheral blood can serve as a “liquid
biopsy” approach and has thus emerged lately as one of the hottest fields in cancer …

A cancer test having prognostic utility in predicting time to disease progression, overall
survival, and response to therapy in patients with MBC based upon the presence and …

Circulating tumour cells (CTCs) can be detected in the blood of many patients with different
types of early or advanced cancer using antibody-based assays or molecular methods. In …

Circulating tumor cells (CTCs) may be detected in the blood of patients with epithelial tumors
using different analytical approaches. The relative number of CTCs is low and they include a …

It has been demonstrated that even localized tumors without clinically apparent metastasis
give rise to circulating tumor cells (CTCs). A growing number of technically diverse platforms …

The measurement and characterization of circulating tumor cells (CTCs) hold promise for
advancing personalized therapeutics. CTCs are the precursor to metastatic cancer and thus …